Followers | 49 |
Posts | 4136 |
Boards Moderated | 0 |
Alias Born | 05/20/2014 |
Tuesday, May 26, 2020 1:15:37 PM
Omni Health is looking to raise $3,250,000
We are offering 40% of the newly-formed entity which will hold all the rights and IP to the products. Additionally, given that Omni Health is a publicly-traded company, the warrants compensation structure will be offered. OMHE stock is currently undervalued; similar companies have enjoyed significant stock increases upon completion of critical milestones such as those already well within our reach. As a case in point, GW Pharma, one of the major players in medical CBD arena, has experienced a stock price increase from $1.20 to its current price of $112.
FEATURED DaBaby and Stunna 4 Vegas's "NO DRIBBLE" Joins Music Licensing, Inc.'s Portfolio • Jun 7, 2024 10:15 AM
Mushrooms Inc. (OTC: MSRM) Announces Significant Share Buy Back by the Board Director and New Strategic Initiatives. • MSRM • Jun 5, 2024 1:32 PM
Hydromer Announces Launch of HydroThrombX Medical Device Coating Technology • HYDI • Jun 5, 2024 10:24 AM
Dr. Michael Dent Finances $1 Million to Drive HealthLynked's Healthcare Transformation • HLYK • Jun 5, 2024 8:00 AM
Avant Technologies Enters Binding LOI to Purchase Dozens of High-Performance, Immersible, AI-Powered Servers • AVAI • Jun 5, 2024 8:00 AM
IQST - iQSTEL Announces $290 Million 2024 Annual Revenue Forecast • IQST • Jun 4, 2024 1:43 PM